Concord farm donates all the produce it grows to fight food insecurity in Massachusetts
Farm in Concord donates everything it produces to combat food insecurity
Farm in Concord donates everything it produces to combat food insecurity
Farm in Concord donates everything it produces to combat food insecurity
One Concord farm is helping to combat food insecurity in Massachusetts by donating all of its produce.
Gaining Ground, a 35-year-old, no-till organic farm, doesn't sell a single fruit or vegetable. Every harvest is donated to people facing food insecurity across Massachusetts.
"We have never sold a single fruit or vegetable," said Jennifer Johnson, executive director of Gaining Ground. "We have given away everything we grow. We're exclusively dedicated to food insecurity."
They said they measure their success, not in sales, but in what they give away to communities in the state.
Helping over 10,000 people across Massachusetts
Their food reaches more than 10,000 people in 41 cities and towns across Greater Boston, Lowell, and the MetroWest area. And the need continues to grow.
In Massachusetts, food insecurity has more than doubled since the pandemic, now affecting one in five households. Rising inflation has made it even harder for many families to afford fresh, healthy food.
"I'm a firm believer that access to nutritious food, the kind you need to live a healthy life, is a human right. Full stop," Johnson said.
Volunteers and staff grow familiar crops like tomatoes, broccoli, and lettuce, but also more culturally specific ones like Brazilian eggplant, Asian greens, and a wide variety of hot peppers.
"We really consider it a gift to be able to give this food to people so that it can nourish them both in body and soul," said Johnson.
One of the farm's longtime partners is House of Hope, a family shelter in Lowell. The organization serves three meals a day to around 200 people, with much of the produce coming from Gaining Ground.
"I've been a chef for years," said Paul Dubuque, who works at House of Hope. "If this produce was going to a restaurant, you'd be paying a lot of money for it."
In 2024 alone, Gaining Ground donated 139,000 pounds of produce. That's enough for more than 650,000 servings. For many, it's not just about nutrition; it's about dignity.
"When people receive Gaining Ground food, they tell us that they have the dignity of being seen as equals," said Johnson.
Long-term sustainability
The farm is also committed to long-term sustainability. By using no-till methods and organic practices, they protect the microbial life in the soil. That's one key to growing nutrient-rich food.
"Good farmers grow vegetables and great farmers grow soil," Johnson said.
"The fungi and bacteria in the soil take the nutrients and transform them the compounds into a readily accessible compound for the plants," said Mark Condon, Director of Agriculture at Gaining Ground.
That makes the plants stronger, the food more nutritious, and the land more resilient... especially as the climate changes.
"No-till really assists when we have a lot of rain or a drought," Condon said. "The soil can act as a sponge to absorb or a great filtration for too much water."
From farm to food pantry, and soil health to human health, Gaining Ground is growing a lot more than vegetables. To learn more or get involved with Gaining Ground, click here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
‘Devastating': 10 Harvard researchers detail ‘essential' work set to be cut by Trump
From a fruit fly database, to developing 'organ chip' technology, to the study of deer mice — all of it could have serious implications for understanding, finding cures for or helping alleviate human diseases, Harvard University researchers say. And yet, those explorations are among thousands of federal research grants and billions of dollars the Trump administration has cut in recent months. In court filings, Harvard — global research mecca — claims it is being targeted by a 'government vendetta,' as President Donald Trump strips much of its federal money and contracts in the name of addressing antisemitism. But what research is actually being done at Harvard? And does it matter if it gets cut? MassLive is profiling 10 researchers, using interviews and court affidavits, whose work will be entirely stopped or severely affected by federal government cuts. A federal judge on Monday ordered the Trump administration to restore 367 National Institutes of Health grants as part of two lawsuits, but the order doesn't apply to a broad swath of grants, including the huge numbers at Harvard. There have been 2,282 NIH grants terminated nationally, amounting to nearly $3.8 billion of lost funding as of June 4, according to the Association of American Medical Colleges. The funding cuts at Harvard have led to layoffs at the Harvard T. H. Chan School of Public Health, as every one of its direct federal grants has been terminated. The school has even taken to social media to ask for donations. Read more: As federal funding cuts hit Harvard, a private investment firm and other donors step up Harvard announced it has committed $250 million of 'central funding' to support research affected by suspended and canceled federal grants. However, even with the boost of funding from the university, research is threatened and could be significantly affected without federal money, according to Harvard researchers. Overwhelmingly, researchers told MassLive that while Harvard may be the facilitator for the work they're doing, it's not 'Harvard research' — rather, it's research for the world. They also argued that the cuts are wasteful and costly because they stop research prematurely, making all funding that came before it nearly useless. Position: Genome database coordinator, a staff scientist position in the Department of Molecular and Cellular Biology at Harvard University Victoria Jenkins extracts, interprets and archives data to keep FlyBase, the world's central repository for fruit fly research, running. The website is a free treasure trove of 32 years' worth of data for scientists across the world to access. Fruit flies are genetically similar to humans — nearly 70% — making them cheap and accessible test subjects to work with. The site contains information about every fruit fly gene and genome. 'We're the Wikipedia of fruit fly research,' Jenkins said in an interview. 'There really isn't a second version of what we do. We are the one resource for this information.' In May, FlyBase's grant funding from the National Institutes of Health was terminated. Now, researchers are searching for other forms of funding to, at the very least, preserve the website as is. Jenkins said Alzheimer's, Parkinson's, addiction, traumatic brain injuries and birth defects have all been modeled in flies as researchers work to make scientific breakthroughs. Six Nobel Prize projects have been awarded to fruit fly-related research. And the results are all found on FlyBase, which is a multi-university partnership between Harvard, Indiana University, University of New Mexico and the University of Cambridge in the United Kingdom. 'Every fly researcher around the world relies on us for historical data and everything new that gets produced,' Jenkins said. Position: Professor of Organismic and Evolutionary Biology at Harvard University When Bence Ölveczky came to the U.S. at the age of 28 from Hungary, it was the first place where he didn't feel like a foreigner. 'This is a unique country because it's a country of immigrants. And that's why I felt at home because nobody cared,' he told MassLive. Now it feels like the climate is changing. He isn't able to encourage students to come to the university. At the same time, he is piecing together funding for his research after the funding terminations. He is working to understand how rats learn, which will inform rehabilitation, helping people who have had strokes or have Parkinson's. 'It's an inspiration to me that we could help in the treatment of these,' he said. Using 'rainy day' funds he received a decade ago from when he was promoted, he hasn't had to lay off staff yet — but these funds will dry up within the year, he said. In addition to potential layoffs, around 100 rats would also have to be euthanized because the lab won't have the funding to keep going. Position: Professor of computational biology and bioinformatics at the Harvard T.H. Chan School of Public Health. He is also the chair of the Department of Biostatistics. For over three decades, John Quakenbush has been working in biomedical research, investigating the mechanisms that cause healthy people — and ultimately their cells — to become diseased. Despite his decades of experience, he said he is looking at leaving the United States. 'I stand behind Harvard in its decision to fight for its First Amendment rights,' Quakenbush said in an interview. 'But I'm looking, at this point in my career, at potentially two years with almost no external research funding — maybe longer. And, as you get to that point, and you're not doing research anymore, picking back up and starting up again becomes more difficult. Even securing federal research grants becomes difficult.' Part of Quakenbush's research is attempting to uncover a 'fundamentally important but understudied problem in health.' He is both unpacking how sex and age interact to influence disease risk and how diseases differ between biological males and females. Without the funding, he doesn't know what'll happen next, but said sex is important to understand how nearly every disease has different ways it manifests or responds to therapy. " The political agenda that we don't want to acknowledge different genders or we don't even want to go beyond individual sexes is sort of ridiculous because disease strikes us all right? Independent of who we voted for, who we love, what church we go to or don't go to," Quakenbush said. Position: Associate professor of social and behavioral sciences at the Harvard T.H. Chan School of Public Health When describing the affects of federal research cuts in a recent court filing, Shoba Ramanadhan used the word 'devastating' multiple times. Four of her federal grants have been terminated or ended early. They included research related to the impact of climate change-caused heat stress and cancer-focused outreach to immigrants, refugees and minority communities. 'I work closely with communities that have been subject to discrimination in the United States, such as racial and ethnic minorities and LGBTQ+ groups,' Ramanadhan wrote in her court affidavit. 'Given historical and current abuses of power, these communities are understandably skeptical of scientists and academic researchers. It can take us anywhere from 5 to 15 years to build the requisite trust and relationships with a community and partner on research.' Ramanadhan warned that if her projects can't be completed, 'people in the communities we serve will not be supported to engage in cancer prevention activities, such as breast cancer screening or vaccination against HPV.' She also expressed concerns that an entire cohort of faculty working toward tenure, herself included, could lose the opportunity to achieve it because of federal research cuts. Kelsey Tyssowski Position: Postdoctoral Research Associate in the Departments of Organismic & Evolutionary Biology and Molecular & Cellular Biology at Harvard University. Without funding for Kelsey Tyssowski's work, she may have to leave academic science entirely. Her pathway to getting a tenure-track job has been halted by federal funding cuts. Her research only has funding until the end of the month — then it is up to tenure faculty to determine if she will have any left. A canceled grant from the National Institutes of Health was supposed to cover her salary through March 2026 and the first three years of research in her own lab. 'I have to get a job this year. And this year it's going to be very hard to get a tenure track faculty job because there's hiring freezes everywhere,' Tyssowski said. 'If I can't stay in this job here, I almost certainly have to leave academia.' Tyssowski's research involves skilled movement, complex learned movements that can be reproduced accurately and efficiently and take entire body coordination to do, like climbing. She is pioneering a new way to study skilled movement through deer mice — whose skilled movement might have evolved in a way that humans and primates have. This could provide significant understanding on how human brains engage in skilled movement, and ultimately, in treating diseases such as ALS, where skilled movement is the first thing to go. If she leaves academia, the work that she has been doing is at risk of completely vanishing. 'No one will do this research. I won't do this research. It will just go away,' she said. Position: Social epidemiologist and director of the Social Policies for Health Equity Research Center at the Harvard T.H. Chan School of Public Health Rita Hamad has spent nearly 20 years studying the effects of social policies on health, poverty and education. Specifically, how policies can have the power to lift up marginalized communities and improve their health, or make it worse. It is an 'unbelievably devastating time for science in general, but particularly for us that study health equity,' she said in an interview. Hamad has seen three of her NIH grants canceled. One was used to study how neighborhood socioeconomic factors affect risk for Alzheimer's and dementia. 'We need to know what about communities we can intervene in to improve these risk factors,' she said. 'If you don't have that information, you're not preventing any cases of dementia.' A second grant was used to examine the effects of school segregation on the cardiovascular health of youth and young adults. Research so far has shown that children who experience school segregation have a higher risk of worse health in childhood and years later, she said. 'All of that research is grinding to a halt, doing a disservice to people of all backgrounds,' Hamad said. 'Clinging to whatever I can,' Hamad said she's trying to remain hopeful that her grant funding will be restored and the damage 'reversible.' 'We're not just here to get a paycheck,' she said. 'We're here to make the world a better and healthier place.' Position: Founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University With Donald Ingber's ongoing work, the U.S. had a better chance at exploring Mars. But the federal government has instructed him to cease his projects. Ingber and his team have been working to develop human 'organ chip' technology — 'tiny, complex, three-dimensional models with hollow channels lined by different types of cells and tissues that recapitulate the structure and function of human organs,' he wrote in a court affidavit. One of Ingber's projects was using the organ chip to study the effects of microgravity and radiation on astronauts during spaceflight. Ingber was developing specialized bone marrow chips incorporating cells from individual astronauts. The specialized chips were scheduled to fly aboard the Artemis II mission to the moon, scheduled for early 2026, alongside the astronauts who donated the cells, Ignber said. 'This work is critical to our ultimate ability to explore Mars, because protecting astronauts from radiation toxicity remains a major barrier to the long-distance space travel necessary to explore the solar system,' he continued. The second project using the organ chip technology was studying how the human lung, intestine, bone marrow and lymph node respond to radiation, with the goal of identifying drugs 'that can mitigate the effects of that radiation.' Ingber said the work was important to improve public safety, 'as the country ramps up nuclear power production to support the energy-intensive artificial intelligence industry.' 'These countermeasures also would be available in the case of a nuclear attack and to alleviate toxic side effects in cancer patients who receive radiation therapy,' he said. Position: Professor of epidemiology and nutrition at the Harvard T.H. Chan School of Public Health Kept frozen by liquid nitrogen inside laboratories at Harvard University are more than 1.5 million biospecimens that have mere 'weeks' left until they spoil. Soon, there won't be enough money left to keep the freezers running. The nearly 50 years of collected human feces, urine, blood, tumors and even toenail clippings could have consequential implications for the future health of Americans, and yet, they're at risk of being lost if funding slashed by the Trump administration isn't restored. Read more: Trump cuts threaten 'irreplaceable' Harvard stockpile of human feces, urine The mother lode collection housed at Harvard has supported generations-long chronic disease risk studies that have fundamentally shaped significant scientific and medical advancements. The studies have led to major breakthroughs, including links between cigarettes and cardiovascular disease and alcohol consumption and breast cancer. The research also uncovered the dangers of trans fats, which the U.S. has now largely restricted. The biological samples collected during the studies are 'irreplaceable,' according to Walter Willett, one of the most sought-after nutritionists internationally. And some of the study participants could even die before the next check-in period, he said. 'No other institution in the world has this data,' Willett wrote in a May 30 court affidavit detailing the effects of federal funding cuts on his research. Position: Senior lecturer in the Department of Biostatistics and Epidemiology at the Harvard T.H. Chan School of Public Health Personally, Paige Williams, a Harvard faculty member of 34 years, stands to lose 90% of her salary due to revocations of NIH grants. Professionally, she fears the downstream effects on clinical research in the future, particularly when it comes to community trust. She cited some of her study participants — women living with HIV — who have already expressed feeling 'betrayed' when study activities abruptly stopped in May. 'As HIV researchers, we rely on the willingness of our study participants to share openly some of the most vulnerable and challenging aspects of their lives,' Williams wrote in a court filing. 'Our work thus depends on a foundation of trust between us and the participants we work with…' Williams primarily studies health outcomes in pregnant women and their children, and much of her work is HIV-centered. One of her terminated grants was a 20-year study evaluating the effects of anti-retroviral treatment for mothers with HIV and their children — currently in its final year. Because of the grant stoppage, her research team was essentially unable to procedurally finish two decades of work. In addition, they're slated to lose data they've collected, Williams wrote. 'Losing the data arising from such studies would be devastating for the entire scientific community and for the many Americans whose lives would be forever improved by scientific breakthroughs,' she said. Position: Professor of Health Economics and Policy in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health & interim department chair. Meredith Rosenthal's research focuses on a tool to lower medication alternatives to help reduce out-of-pocket costs for patients and increase medication adherence. She is aiming to understand how things may change based on people's socioeconomic statuses and geographic locations. Around 60% of Rosenthal's salary comes from research grants. One of her grants provides almost $2.5 million over three and a half years, and she has one year left. Her grant was canceled on May 15, according to court documents. 'I firmly believe that equity is an essential value in health policy. I have dedicated my career to improving health and affordability for everyone, both through my research and by overseeing the school's Office of Diversity and Inclusion (from 2013-2018) to improve diversity, equity and inclusion of those who work in the industry and on our campus,' she said. 'I worry that the Trump administration will label my focus on equitable access to healthcare as an 'ideologically capture' DEI program and demand that the school 'shutter' the program, particularly because of my former diversity-related administrative role, but because of the vagueness of the Demand Letters, I cannot be sure,' she said. Federal judge halts Trump's plans to keep Harvard from enrolling foreign students Harvard researcher's work gives 'hope' for Parkinson's. But the feds cut his funding These US colleges are among the top 100 best global universities, US News says 'Far reaching consequences' — UMass Amherst sounds the alarm amid federal uncertainty MIT joins group of universities suing the DOD over funding cuts Read the original article on MassLive.
Yahoo
2 days ago
- Yahoo
How Is Hologic's Stock Performance Compared to Other Health Care Equipment Stocks?
With a market cap of $14.3 billion, Hologic, Inc. (HOLX) is a Massachusetts-based medical technology firm, primarily focused on women's health. The company develops, manufactures, and sells a comprehensive suite of solutions, including molecular diagnostics, medical imaging systems, and surgical devices Companies worth $10 billion or more are generally described as 'large-cap stocks,' and Hologic fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical instruments & supplies industry. The company benefits from robust innovation, supported by over 7,000 patents, which fuels its proprietary technologies and product differentiation. Its diagnostics segment, particularly in molecular testing, has shown strong growth, positioning Hologic well in the expanding global healthcare market. 2 Outstanding Stocks Under $50 to Buy and Hold Now Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? A $1 Billion Reason to Buy MicroStrategy Stock Here Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. However, HOLX shares have retreated 24.5% from their 52-week high of $84.67 touched on Aug. 9, 2024. Meanwhile, HOLX stock has surged 3.2% over the past three months, surpassing the SPDR S&P Health Care Equipment ETF's (XHE) 4.8% plunge over the same time frame. HOLX stock has plummeted 11.3% on a YTD basis and 10.5% over the past 52 weeks, compared to XHE's 10.6% dip in 2025 and a 6.3% fall over the past year. The stock has remained consistently below its 200-day moving average since early December last year, but has climbed above its 50-day moving average since late May. On May 27, HOLX shares surged more than 14%, leading S&P 500 gainers, after reports emerged that TPG Inc. (TPG) and Blackstone Inc. (BX) made (and were turned down on) a non-binding ~$16 billion takeover bid, valuing the company at $70–$72 per share. The stock's rally reflected investor optimism and underscored the premium valuation placed on its leadership in women's health and diagnostic capabilities. In the competitive healthcare equipment industry, top rival, Align Technology, Inc.'s (ALGN) 13.7% drop on a YTD basis and 25.7% decline over the past year trails HOLX's losses in the same time frames. Among the 19 analysts covering the HOLX stock, the consensus rating is a 'Moderate Buy.' Its mean price target of $68.27 suggests a 6.7% upside potential from current price levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
Community collaboration crucial in addressing homelessness in Abilene
ABILENE, Texas () – Young professionals gathered at the Community Foundation of Abilene for an 'Abi Chat' during the Abilene Young Professionals luncheon. Networking took a purposeful turn to address homelessness through collaboration with the West Texas Homeless Network. The West Texas Homeless Network (WTHN) is a coalition of organizations dedicated to advocating for action that realigns systems and resources to end homelessness in Abilene, rather than merely managing it. The WTHN is neither a non-profit nor a for-profit organization; instead, it focuses on helping communities prevent and eliminate homelessness through collaboration and strategic planning. The Executive Director of Abilene Hope Haven shared why events like this are important in keeping the conversation with the public and continuing to address the needs of the Big Country Homeless community. 'We have a great network of people. We always are going to need to fill different gaps, depending on what's going on in the climate of our community. But we have a wealth of providers in the network that are really good at doing a holistic approach to those experiencing homelessness,' Horton shared. Horton says the Abilene community's wealth of resources and willingness to work together are its strengths. Whether a person needs help with mental health, food insecurity, substance abuse, or any number of issues that homeless neighbors face, the network is ready and willing to step in. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
